Sentence examples for multiple sclerosis treated from inspiring English sources

The purpose of this study is to report a case of bilateral acute retinal necrosis in a patient with multiple sclerosis treated with natalizumab.

This study was a prospective, observational, non-interventional study of patients with relapsing remitting multiple sclerosis treated with glatiramer acetate conducted in Germany.

Her medical history was significant for multiple sclerosis treated with interferon 1β and a venous thromboembolic disorder managed with oral warfarin.

Bensmail et al. showed that patients with severe spasticity due to spinal cord injury and multiple sclerosis, treated with ITB by bolus administration, showed an increased respiratory disturbance index (the number of apneas/hypopneas per hour of sleep) [ 28, 29].

Due to detailed brain autopsies, natalizumab, a novel antibody directed to the adhesion molecule a4 integrin, was identified as a risk factor for development of progressive multifocal leukoencephalopathy in patients with Crohn's disease or multiple sclerosis treated with this drug [ 28].

30 In RA, six cases with progressive multifocal leukoencephalopathy (PML) have been reported (Roche data on file), including one case from the REFLEX trial 3 giving an incidence of less than 1 20 000 treated RA patients, compared with PML risks for patients with psoriasis treated with efalizumab (1 400) and patients with Crohn's disease and multiple sclerosis treated with natalizumab (1 1000).

In 1890, when multiple sclerosis was treated with herbs and bed rest, life expectancy was five years.

In the conference call, Mr. Termeer said that he and Mr. Viehbacher differed over the degree of certainty they felt regarding prospects for Lemtrada, which, he said, would change how multiple sclerosis was treated.

In this study, we identified putative clinical response markers in the serum and plasma of people with multiple sclerosis (MS) treated with IFNβ.

Occurrence of retinal hemorrhage warrants careful follow-up for multiple sclerosis patients treated with fingolimod.

There are few studies that provide controlled trial data in other autoimmune diseases; however, in the HERMES study where relapsing-remitting multiple sclerosis was treated with rituximab or a placebo, a greater proportion of patients in the placebo group had serious infectious events than those receiving rituximab (5.7% versus 2.9%) [ 56].